Bodyport
PrivateLast Round
Series A
Aug 11, 2020
Est. Valuation
$1.71M
Total Funding Raised
$20.4M
Company Overview
Bodyport operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in August 2020.
Bodyport is a healthcare technology company that develops a biomarker platform integrated into at-home devices to noninvasively measure hemodynamic biomarkers for the management of chronic conditions like heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bodyport Comparables
Compare Bodyport with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Respirix, Inc. | 90% | |
| Cardiosense | 86% | |
| VoluMetrix | 82% |
For institutional investors. Book with your work email.
Bodyport Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 11, 2020 | ||||
| Seed | Apr 1, 2018 | ||||
| Seed | Feb 1, 2018 | ||||
| Accelerator | Aug 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bodyport Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Playground Global | Series A, Seed |
| Initialized Capital Management | Series A, Seed |
| Kapor Capital | Series A |
| HCVC | Series A |
| Y Combinator | Series A, Seed, Accelerator |
| Boehringer Ingelheim Venture Fund | Series A |
| Regah Ventures | Series A |
Bodyport Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bodyport's valuation, stock price, and market status.
Is Bodyport a public or private company?
Bodyport is a private company.
What is the current stock price of Bodyport?
Bodyport is a private company, so its shares have no public market price. Caplight tracks Bodyport's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bodyport worth (valuation)?
Bodyport's valuation is estimated at $1.7M based on funding round data.
Can I buy Bodyport stock?
Bodyport shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bodyport's last funding round?
Bodyport's most recent funding round was Series A on August 11, 2020.
Who are the main investors in Bodyport?
Key investors in Bodyport include Initialized Capital Management, Y Combinator, Boehringer Ingelheim Venture Fund.
Will Bodyport IPO soon?
No public IPO plans have been announced for Bodyport.
How can I track Bodyport secondary market activity?
Caplight tracks bids, offers, and trades in Bodyport's shares on secondary markets.